Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers. 

Share:
More In Science
Need2Know: February 16, 2023
One people killed in a shooting in El Paso, Ohio residents are worried about health issues after a serious train derailment, and there has been a decrease in overdose deaths in the U.S. Here is everything you Need2Know for Thursday, February 16, 2023.
Load More